BEIJING (Reuters) – China has given conditional approval for general public use to a COVID-19 vaccine developed by China National Biotec Group (CNBG), an official with China’s National Medical Products Commission told a media briefing on Thursday.
The approval is the first for general public use among a handful of Chinese coronavirus vaccine candidates in various stages of development.
(Reporting by Roxanne Liu and Tony Munroe; Editing by Christian Schmollinger)
